Monday July 16, 2018
Home India India condemn...

India condemns support systems for terrorists in South Asia, expresses concern over North Korea’s nuclear program

Sushma Swaraj’s statement assumes significance as it comes after the unprecedented BRICS Summit joint statement earlier this month in which Brazil, Russia, India, China, and South Africa unequivocally named Pakistan and the terror groups based there

0
//
31
Sushma Swaraj talks about support systems of terrorists in South Asia
External affairs minister of India, Sushma Swaraj. Wikimedia
Republish
Reprint
  • India on Thursday condemned support systems for terrorists in South Asia while expressing concern over South Asia’s nuclear program
  • Sushma Swaraj’s statement is significant since it comes after the BRICS Summit where many countries unequivocally named Pakistan and the terrorist groups based there
  • Sushma Swaraj also sought cooperation for early conclusion of negotiations and adoption of the India-initiated Comprehensive Convention against International Terrorism

New York, Sep 22, 2017:  In an obvious reference to Pakistan, India on Thursday condemned support systems for terrorists in South Asia while expressing concern over North Korea’s nuclear and weapons and ballistic missile programmes.

“The horror of terrorism continues to haunt global peace and security. Terror groups draw sustenance from support systems in South Asia,” Sushma Swaraj said while speaking at the BRICS Ministerial Meeting on the margins of the UN General Assembly Session here.

“They continue to find support and shelter in countries which use terrorism as an instrument of state policy.

“We must condemn efforts, including by states, to use religion to justify, sustain and sponsor terrorism against other countries,” she added.

Sushma Swaraj’s statement assumes significance as it comes after the unprecedented BRICS Summit joint statement earlier this month in which Brazil, Russia, India, China, and South Africa unequivocally named Pakistan and the terror groups based there.

“There is need for collective efforts to disrupt terrorist networks, their financing and movement,” she said, calling for terrorist funding, their weapons supply, training and political support to “be systematically cut off”.

Sushma Swaraj also sought cooperation for early conclusion of negotiations and adoption of the India-initiated Comprehensive Convention against International Terrorism (CCIT) in the UN Security Council.

On North Korea’s recent offensive military posturing, she said: “The action and rhetoric of North Korea has been a source of growing global concern.”

Also read: Baloch Activist Bugti hails Sushma Swaraj for her speech against Pakistan Atrocities at UN General Assembly

She also touched on climate change and referred to Indian Prime Minister Narendra’s Modi’s suggestion of an alliance between the India-initiated International Solar Alliance and the New Development Bank, a multilateral development bank established by the BRICS nations.

“I hope we can work together to give this ambitious agenda practical shape in coming months,” she said.

The International Solar Alliance, launched at the UN Conference of Parties (CoP) climate summit in Paris on November 30, 2015, by Prime Minister Modi and then French President Francois Hollande, is conceived as a coalition of solar resource-rich countries to address their special energy needs and provide a platform to collaborate on dealing with the identified gaps through a common, agreed approach.

It is open to all 121 prospective member countries falling between the Tropics of Cancer and Capricorn. (IANS)

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)